A top pick in smallcap health. They made PPP during Covid then bought two companies in home healthcare. Sales rose 24% in 2023, though PPP declined. They just projected EPS growing 20% annually.
Stock price when the opinion was issued
As of Jul 30, 2026. Market Open.
Build your watch list
Sign in to track investmentsyou care about
Black Swan Dexteritas
Stockchase Premium
Stockchase
CNBC
Kingwest & Company
A top pick in smallcap health. They made PPP during Covid then bought two companies in home healthcare. Sales rose 24% in 2023, though PPP declined. They just projected EPS growing 20% annually.